Technology cost versus benefits
This article was originally published in The Gray Sheet
HHS task force charged with encouraging medical innovation should consider ways HHS "can document and measure the collective value to society of advances in healthcare, to ensure that the benefits of innovation are fully recognized and accounted for," The Value Group maintains in an 1Aug. 23 letter. Comprised of healthcare industry leaders, including AdvaMed, The Value Group released a report touting the benefits of new technology earlier this year (2"The Gray Sheet" Feb. 2, 2004, p. 3)...
You may also be interested in...
Medical technology advances from 1980-2000 helped prevent 470,000 deaths, 2.3 mil. disabilities and 206 mil. days spent in the hospital, according to a study released Jan. 28
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.